Paragon Technologies'
SI/Baker Joint Venture Wins $3 Million Contract For Automated
Pharmacy Fulfillment System
- e-Commerce
Fulfillment System To Allow Same Day Shipment Of Orders
EASTON, PA - July 12, 2000 - Paragon
Technologies, Inc. (AMEX:PTG), a leader in fully automated
and integrated material handling and conveyer systems, today
announced that it's SI/Baker joint venture with McKessonAPS,
a subsidiary of McKessonHBOC (NYSE:MCK), was awarded a contract
for approximately $3 million to provide an automated e-pharmacy
fulfillment system.
SI/BAKER's client will provide internet customers
with prescription medications, non-prescription medications,
health and beauty aids, home medical supplies and a resource
for drug and health information, and will use the automated
fulfillment system to provide same day shipment for prescription
and non-prescription health and wellness orders.
The SI/BAKER automated pharmacy fulfillment
system will have an initial capacity of 4,000 prescriptions
and 11,000 health and wellness (non-prescription medications,
health & beauty aids and home medical supplies) lines per
shift. The fulfillment system will initially handle over
10,000 sku's and have the ability to nearly double capacity
and sku count by simply adding stations. Completion of the
Pharmacy Fulfillment System is scheduled for fall 2000.
SI/BAKER, INC., a joint venture company equally
owned with McKessonAPS, a subsidiary of McKessonHBOC (NYSE:MCK),
is the leading supplier of automated prescription fulfillment
systems for high volume pharmacies. SI/BAKER has installed
over 40 integrated prescription fulfillment systems, ranging
in size from 1,000 to over 20,000 prescriptions per shift,
for mail order, central fill and internet pharmacy applications.
SI/BAKER employs advanced engineering and proven technology
to create the most accurate and efficient pharmacy systems
in the industry.
Bill Johnson, President and CEO of Paragon
Technologies, said, "We are proud to have SI/Baker chosen
to design and install the new system, and look forward to
implementing similar projects at other pharma firms across
the U.S. This reinforces our strong belief in automated
prescription fulfillment for pharmaceutical companies as
a major growth opportunity. We are absolutely committed
to a successful implementation." Johnson concluded, " Paragon
is steadily becoming the source for e-commerce fulfillment
solutions, and our SI/Baker subsidiary continues to lead
the way in the pharma world. "
With headquarters
in Easton, PA, Paragon Technologies markets, designs, manufacturers,
installs and services fully automated, integrated material
handling systems and Ermanco conveyor systems that improve
productivity in manufacturing, provide e-commerce fulfillment
solutions, and increase the speed of delivery of products
in most categories by companies worldwide. One of the top
materials handling systems suppliers worldwide and ISO 9001
certified, Paragon's leading clients include General Motors,
IBM, BMG, DaimlerChrysler, Johnson & Johnson, the U.S. Postal
Service, Ford, Peterbilt, Harley-Davidson, McKesson, Walgreen,
Clark Equipment and CVS.com.
Cautionary Statement. Certain
statements contained herein are not based on historical fact and are "forward-looking
statements" within the meaning of the Private Securities Litigation Reform
Act of 1995 and the Securities and Exchange Commission rules, regulations and
releases. Paragon intends that such forward-looking statements be subject to the
safe harbors created hereby. Among other things, the forward-looking statements
regard Paragon's earnings, liquidity, financial condition, and certain operational
matters. Words or phrases denoting the anticipated results of future events, such
as "anticipate," "does not anticipate," "should help
to," "believe," "estimate," "is positioned,"
"expects," "may," "will," "is expected,"
"should," "continue," and similar expressions that denote
uncertainty, are intended to identify such forward-looking statements. Paragon's
actual results, performance, or achievements could differ materially from the
results expressed in, or implied by, such "forward-looking statements:"
(1) as a result of risks and uncertainties associated with Paragon's restructuring,
including the failure to achieve anticipated operating savings, and the possibility
that the restructuring charges will be greater than anticipated; (2) as a result
of factors over which Paragon has no control, including the strength of domestic
and foreign economies, sales growth, competition, and certain cost increases;
or (3) if the factors on which Paragon's conclusions are based do not conform
to its expectations.